We would love for you to become a part of our community. Join our Discord to connect with us and other members!

Ticker
BAYNN.MX

Price
-
Stock movement down
-18.20 (-3.25%)
Company name
Bayer Aktiengesellschaft
Exchange
(MX
,
Currency
MXN
)
Market cap
532.28B
Ent value
609.55B
Price/Sales
11.17
Price/Book
16.09
Div yield
-
Div growth
-
Growth years
-
FCF payout
200.30%
Trailing P/E
-
Forward P/E
-
PEG
-
EPS growth
-
1 year return
-52.53%
3 year return
-24.76%
5 year return
-16.35%
10 year return
-11.41%
Last updated: 2024-12-17

DIVIDENDS

BAYNN.MX does not pay dividends or no data was received

VALUATION

Valuation Ratios

Loading...
Valuation Ratios data
Trailing P/E-
Price to OCF104.02
Price to FCF224.97
Price to EBITDA208.16
EV to EBITDA238.39

Valuation (Sales/Book Value)

Loading...
Valuation (Sales/Book Value) data
Price to Sales11.17
Price to Book16.09
EV to Sales12.80

FINANCIALS

Per share

Loading...
Per share data
Current share count982.42M
EPS (TTM)-2.99
FCF per share (TTM)2.41

Income statement

Loading...
Income statement data
Revenue (TTM)47.64B
Gross profit (TTM)27.89B
Operating income (TTM)8.04B
Net income (TTM)-2.94B
EPS (TTM)-2.99
EPS (1y forward)-

Margins

Loading...
Margins data
Gross margin (TTM)58.54%
Operating margin (TTM)16.87%
Profit margin (TTM)-6.17%

Balance Sheet

Loading...
Please create a free account or log in to access this chart
Balance Sheet data
Cash5.91B
Net receivables9.34B
Total current assets37.56B
Goodwill32.30B
Intangible assets23.36B
Property, plant and equipment29.26B
Total assets116.26B
Accounts payable7.46B
Short/Current long term debt0.00
Total current liabilities29.46B
Total liabilities83.18B
Shareholder's equity33.08B
Net tangible assets0.00

Cash flow

Loading...
Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)5.12B
Capital expenditures (TTM)2.89B
Free cash flow (TTM)2.37B
Dividends paid (TTM)4.74B

Financial returns

Loading...
Please create a free account or log in to access this chart
Financial returns data
Return on Equity-8.89%
Return on Assets-2.53%
Return on Invested Capital-4.18%
Cash Return on Invested Capital3.37%

STOCK INFORMATION

Downside potential

Loading...
Downside potential data
BAYNN.MXS&P500
Current price drop from All-time high-79.41%-0.42%
Highest price drop-79.41%-56.47%
Date of highest drop1 Feb 20249 Mar 2009
Avg drop from high-32.11%-11.12%
Avg time to new high28 days12 days
Max time to new high1577 days1805 days
COMPANY DETAILS
BAYNN.MX (Bayer Aktiengesellschaft) company logo
Marketcap
532.28B
Marketcap category
Large-cap
Description
Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and digital solutions, and contrast agents, as well as cell and gene therapy. The Consumer Health segment markets nonprescription over-the-counter medicines for self-medication and self-care; and solutions for nutritional supplements, allergy, cough and cold, dermatology, pain and cardiovascular risk prevention, and digestive health. The Crop Science segment offers seeds, improved plant traits, innovative chemical and biological crop protection products, digital solutions, as well as customer service for agriculture. This segment also provides breeding, propagation, and production/processing of seeds, including seed dressing. The company has a collaboration with Acuitas Therapeutics, Inc. to strengthen gene editing programs; Peking University in the area of basic pharmaceutical research; the Swiss Tropical and Public Health Institute in the development of the compound emodepside for the treatment of infection with soil-transmitted helminths; bit.bio Ltd. for the discovery and manufacture of regulatory T cells for use in creating therapeutics; Hologic, Inc. in the field of contrastenhanced-mammography solutions to improve diagnostic imaging for the detection of breast cancer; and Twist Bioscience Corporation centering around the research and development of antibody-based pharmaceuticals, as well as with CrossBay Medical Inc. It distributes its products through wholesalers, pharmacies and pharmacy chains, supermarkets, online and other retailers, and hospitals, as well as directly to farmers. The company has collaboration with Thermo Fisher Scientific. Bayer Aktiengesellschaft was founded in 1863 and is based in Leverkusen
Employees
96931
Investor relations
-
CEO
Country
Mexico
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
No items found